Skip to main content

MoneyWorks4Me

Gland Pharma informs about analyst meet

28 Jul 2021 Evaluate

Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it has enclosed the schedule of Analyst/ Institutional Investor Meetings with the Company. The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on the part of Investor/ Analyst/ Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..